UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC CFI 145/2024

May 13, 2024·EP2493466 +1 more: NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details
Status
Case Closed
Action
Infringement
Category
Main Infringement Action
Parties
Respondents
Reps: Jules Fabre (Pinsent Mason); Arjan Reijns (Pinsent Mason); Daniel Hoppe (Bonabry); Christian Meyer (Maiwald); Anja Lunze (Taylor Wessing)
Division
Munich LD
Judges
Technology
Pharmaceuticals · Small Molecule · Pharmaceutical & Medical
Language
English
Decisions
  • 2025-07-17
    Generic Order

    Procedural order of the Munich Local Division (presiding judge Zigann) following the interim conference of 17 July 2025 in four consolidated pharmaceutical patent infringement actions by Sanofi and related entities against generics companies (Accord Healthcare, STADA, Dr. Reddy's, Zentiva) concerning EP 2 493 466. Points addressed: EPO Board of Appeal had upheld the patent but had not yet published its written reasoned decision; French parallel first-instance decisions invalidating the French designation were under appeal; defendants wished to comment on EPO BoA written reasons within three weeks of availability. No substantive infringement ruling.

    Legal issues:Interaction between EPO Board of Appeal proceedings and UPC validity determinationFrench parallel invalidity decisions under appealCase management following interim conference
  • 2025-05-08
    Generic Order

    Procedural order in consolidated Sanofi v. Accord Healthcare / Dr Reddy's / betapharm infringement proceedings at Munich Local Division. The judge-rapporteur declined to dispose of the case summarily and determined it would be more efficient to await the outcome of pending EPO Board of Appeal proceedings concerning the patent before deciding difficult substantive issues at an oral hearing.

    Legal issues:Case management in parallel EPO Board of Appeal and UPC proceedingsProportionality of ordering premature evidence productionDecision on strike-out of Malta from revocation counterclaim
  • 2025-05-08
    Generic Order

    Procedural order from Munich Local Division dated 8 May 2025 (unredacted version) in the consolidated infringement proceedings of Sanofi against Accord Healthcare, Stada, Dr. Reddy's and Zentiva regarding EP 2 493 466. The order sets the timetable for further proceedings, confirms the interim conferences (including one focused on EPO BoA appeal outcome on 17 July 2025), and sets the main interim conference for 12 September 2025 and oral hearing dates for 14–17 October 2025. The order also addresses outstanding procedural issues including Zentiva's request to strike Malta from the revocation request, and provides guidance on the panel's preliminary views on damages calculation and infringement.

    Legal issues:Case management and schedulingStay pending EPO BoA outcomeDamages calculation guidanceStrike-out of Malta from revocation claim
  • 2025-01-14
    Application RoP262A

    Procedural order from Munich Local Division dated 14 January 2025 regarding R. 262A RoP confidentiality applications filed by defendants (Accord Healthcare, Stada, Dr. Reddy's, Zentiva) in Sanofi's infringement actions concerning EP 2 493 466. The order defines which representative and company personnel on each defendant's side are permitted access to unredacted versions of confidential documents produced in the proceedings.

    Legal issues:Confidentiality protection of documents under R. 262A RoPAccess restrictions for party representatives
Documents
Document titleDatePublic
action.phaseChange.caseClose2025-11-27Not public
Other Documents2025-11-19Not public
action.phaseChange.oralPhaseClose2025-10-11Not public
action.issueDecision.decision2025-10-11Not public
Final Order2025-10-11Public
Cover sheet2025-10-10Not public
Application2025-10-10Not public
Signature image2025-10-10Not public
Receipt2025-10-10Not public
Cover sheet2025-10-10Not public
Other document2025-10-10Not public
Receipt2025-10-10Not public
Headnote-and-Keywords2025-09-15Not public
Interim-Procedure-Closure2025-09-15Not public
Summon-Oral-Hearing2025-09-15Not public
summons party expert witnesses2025-09-15Public
R 105.5 - 2nd interim conference - 12 Sep. 20252025-09-15Public
Hearing-Dates2025-09-15Not public
R 105.5 - 2nd interim conference - 12 Sep. 20252025-09-15Not public
oral hearing reference - IC2025-09-15Not public
oral hearing reference - IC2025-09-15Not public
Fix-Interim-Conference-Date2025-09-10Not public
Interim-Conference-Decision2025-09-10Not public
Written-Procedure-Closure2025-09-10Not public
Receipt2025-09-02Not public
Receipt2025-09-02Not public
Application2025-09-01Not public
2025.09.01 ACT_16112-2024 and 4499-2024 Accord comments_Rule 9 RoP2025-09-01Not public
Anonymized decision bis - 22245-2025 - 17.07.20252025-08-07Not public
Anonymized decision 22245-2025 - 17.07.20252025-08-07Not public
Headnote-and-Keywords2025-07-17Not public
Headnote-and-Keywords2025-07-17Not public
R 105.5 RoP2025-07-17Public
R 105.5 RoP2025-07-17Not public
R 105.5 RoP2025-07-17Public
Outcome of the Order2025-07-16Not public
262 A - final (again for the old CMS)2025-07-16Public
262 A - final2025-07-16Public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-11Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
ACT_16112-2024 and 4499-2024 Accord Application 262A RoP 8 July 2025.pdf2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder REDACTED version 8 July 2025.2025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Acknowledgement-of-lodging2025-07-09Not public
Exhibit TW 6.3 - Paris Court Judgment issued on 6 September 2024 Accord v Sanofi RG 21-06416.pdf2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Exhibit TW 8.8 UPC_CFI_145-2024 (LD Munich) Order of 27 February 2025.pdf2025-07-09Not public
Exhibit TW 5.35bis Sanofi Annual Report 20-F 2008 in the US (complete version).pdf2025-07-09Not public
Exhibit TW 6.5 Schedule of costs for the Defendants as of 8 July 2025 (signed).pdf2025-07-09Not public
Exhibit TW 8.4 UPC_CFI_145-2024 (LD Munich) order of 3 January 2025.pdf2025-07-09Not public
Exhibit TW 8.16 Accord s Comments on Sanofi s further amended requests - filed 9 April 2025.pdf2025-07-09Not public
Exhibit TW 8.7 UPC_CFI_145-2024 (LD Munich) order of 22 January 2025.pdf2025-07-09Not public
Exhibit TW 8.5 UPC_CFI_145-2024 (LD Munich) order of 9 January 2025.pdf2025-07-09Not public
Exhibit TW 6.4 Sanofi Winthrop Industries annuals report for the period 2020 2025.pdf2025-07-09Not public
Exhibit TW 8.10 UPC_CFI_148-2024 (LD Munich) Order of 27 June 2025.pdf2025-07-09Not public
Exhibit TW 8.9 UPC_CFI_145-2024 (LD Munich) Order of 8 May 2025 REDACTED version.pdf2025-07-09Not public
Exhibit TW 8.11 Accord s Preliminary Objections and Generic Procedural Application - filed 1 July 2024.pdf2025-07-09Not public
Exhibit TW 8.6 UPC_CFI_145-2024 (LD Munich) order of 14 January 2025.pdf2025-07-09Not public
Exhibit TW 8.3 UPC_CFI_145-2024 (LD Munich) order of 19 December 2024.pdf2025-07-09Not public
Exhibit TW 7.2 Extracts W Tilmann and C Plasmann Unified Patent Protection in Europe A Commentary book 1st Ed published2025-07-09Not public
Exhibit TW 6.4 Sanofi Winthrop Industries annuals report for the period 2020 2025.pdf2025-07-09Not public
Exhibit TW 8.2 UPC_CFI_145-2024 (LD Munich) order of 5 November 2024.pdf2025-07-09Not public
Exhibit TW 6.3 - Paris Court Judgment issued on 6 September 2024 Accord v Sanofi RG 21-06416.pdf2025-07-09Not public
Exhibit TW 8.15 Official communication 3 March 2025 from Accord UPC representatives to Sanofi UPC representatives.pdf2025-07-09Not public
Exhibit TW 8.1 UPC_CFI_145-2024 (LD Munich) orders of 1st October 2024.pdf2025-07-09Not public
Exhibit TW 8.13 Accord Comments on 262A Sanofi s request - filed on 12 November 2024.pdf2025-07-09Not public
Exhibit TW 8.12 Accord s Rejoinder to the Sanofi s comments on the Preliminary Objections - filed 11 October 2024.pdf2025-07-09Not public
ACT_16112-2024 and 4499-2024 Accord Reply to the Defence to the Counterclaim and Rejoinder UNREDACTED version 8 July 2022025-07-09Not public
Exhibit TW 8.14 Accord Comments on Sanofi amended requests and Rejoinder to Sanofi comments - filed on 12 February 2025.2025-07-09Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Acknowledgement-of-change-of-a-representative2025-05-23Not public
Application-RoP293-Receipt2025-05-22Not public
Formal-checks_Notification-of-positive-outcome2025-05-22Not public
Application-RoP293-Receipt2025-05-22Not public
Formal-checks_Notification-of-positive-outcome2025-05-22Not public
Application-RoP293-Receipt2025-05-22Not public
Formal-checks_Notification-of-positive-outcome2025-05-22Not public
Application-RoP293-Receipt2025-05-22Not public
Formal-checks_Notification-of-positive-outcome2025-05-22Not public
Application-RoP293-Receipt2025-05-22Not public
Formal-checks_Notification-of-positive-outcome2025-05-22Not public
Application-RoP293-Receipt2025-05-22Not public
Formal-checks_Notification-of-positive-outcome2025-05-22Not public
Application-RoP293-Receipt2025-05-22Not public
Formal-checks_Notification-of-positive-outcome2025-05-22Not public
Acknowledgement-of-change-of-a-representative2025-05-22Not public
Application-RoP2932025-05-22Not public
Application - Change of Representative - Jules Fabre Signed 20250519.pdf2025-05-22Not public
Application-RoP2932025-05-22Not public
Application - Change of Representative - Jules Fabre Signed 20250519.pdf2025-05-22Not public
Application-RoP2932025-05-22Not public
Application - Change of Representative - Jules Fabre Signed 20250519.pdf2025-05-22Not public
Application-RoP2932025-05-22Not public
Application - Change of Representative - Jules Fabre Signed 20250519.pdf2025-05-22Not public
Application-RoP2932025-05-22Not public
Application - Change of Representative - Jules Fabre Signed 20250519.pdf2025-05-22Not public
Application-RoP2932025-05-22Not public
Application - Change of Representative - Jules Fabre Signed 20250519.pdf2025-05-22Not public
Application-RoP2932025-05-22Not public
Application - Change of Representative - Jules Fabre Signed 20250519.pdf2025-05-22Not public
Application-RoP293-Receipt2025-05-21Not public
Formal-checks_Notification-of-positive-outcome2025-05-21Not public
Application-RoP2932025-05-19Not public
Application Change of Representative2025-05-19Not public
Comments2025-05-15Not public
Preliminary_Objection_DecisionOutcome2025-05-14Not public
R 20.22025-05-14Not public
R 20.22025-05-14Public
Hearing Reference2025-05-14Not public
Hearing Reference2025-05-14Not public
confidentialty - oberservations2025-05-11Not public
order 8 May 2025 tailored2025-05-11Not public
order 8 May 2025 tailored2025-05-11Not public
Template-Order2025-05-11Not public
Headnote-and-Keywords2025-05-09Not public
Outcome of the Order2025-05-08Not public
final order2025-05-08Public
final order2025-05-08Not public
Outcome of the Order2025-05-08Not public
final order2025-05-08Public
final order2025-05-08Not public
Outcome of the Order2025-05-08Not public
final order2025-05-08Public
final order2025-05-08Not public
final order2025-05-08Not public
final order2025-05-08Public
2025 04 09 -Accord comments on Sanofi amended requests ACT_16112 2024 CC_44999 2024 (workflow 10064-2025)2025-04-09Not public
Exhibit PM 8 - Official communication 3 March 2025 from Accord UPC representatives to Sanofi UPC representatives2025-04-09Not public
Outcome of the Order2025-03-21Not public
262 A - final2025-03-21Public
262 A - final2025-03-21Public
Comments No. 2 Rule 105(5) RoP (Accord - redacted)2025-03-20Not public
Comments No. 2 Rule 105(5) RoP (Accord - unredacted)2025-03-20Not public
Exhibit No. F.062025-03-20Not public
Exhibit No. F.032025-03-20Not public
Exhibit No. B.01.1.2.b2025-03-20Not public
Comments No. 2 Rule 105(5) RoP (Accord - unredacted)2025-03-20Not public
Exhibit No. F.052025-03-20Not public
Exhibit No. B.01.1.c2025-03-20Not public
Exhibit No. F.042025-03-20Not public
comments2025-02-27Not public
Exhibit PM 7 Extracts W Tilmann and C Plasmann Unified Patent Protection in Europe _ A Commentary 1st Ed 20182025-02-12Not public
2025 02 12 Accord comments on Sanofi amended requests ACT_16112 2024 CC_44999 2024 (Workflow 3577_2025)2025-02-12Not public
Comments 263 RoP2025-01-29Not public
Final Order R 105.5 anonymized2025-01-23Not public
Headnote-and-Keywords2025-01-22Not public
R 105.5 - 15 Jan. 20252025-01-22Public
R 105.5 - 15 Jan. 20252025-01-22Not public
Exhibit No. D.04 - New redacted version2025-01-17Not public
Headnote-and-Keywords2025-01-17Not public
Outcome of the Order2025-01-17Not public
R 305 second - final2025-01-17Public
Hearing Reference2025-01-16Not public
Hearing Reference2025-01-16Not public
2025-01-14 Sanofi EP 2 493 466 - R 262A - final_anonymized2025-01-15Not public
Headnote-and-Keywords2025-01-14Not public
R 262 A - final2025-01-14Public
R 262 A - final2025-01-14Not public
Hearing-Dates2025-01-13Not public
R 305 second- oral comments2025-01-13Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Receipt2025-01-09Not public
Hearing-Dates2025-01-09Not public
R 19 - oral argument hearing2025-01-09Not public
Application2025-01-09Not public
Exhibit No. A.02.22025-01-09Not public
R 262 A - comments2025-01-03Not public
Outcome of the Order2024-12-19Not public
extension request2024-12-19Public
Receipt2024-12-13Not public
Reply and Defence2024-12-13Not public
Receipt2024-12-10Not public
2024 12 09 - Accord - Request for extension of deadline2024-12-09Not public
Acknowledgement-of-lodging2024-12-05Not public
2024 12 05 - Application to change details of a representative 59177-20242024-12-05Not public
R 37.2 final signed2024-11-12Public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
Exhibit PM 6.2 Order 7 June 2022 First Instance Court2024-11-12Not public
55583-2024 - 2024 11 12 - Accord comments on Sanofi application for protection of confidential information 262A2024-11-12Not public
Exhibit PM 6.2 Order 7 June 2022 First Instance Court2024-11-12Not public
Comment on application RoP 262A2024-11-05Not public
Application2024-11-01Not public
Exhibit No. D.04 (REDACTED)2024-11-01Not public
Exhibit No. D.04 (UNREDACTED)2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Exhibit No. B.04.62024-11-01Not public
Exhibit No. G.042024-11-01Not public
Exhibit No. B.132024-11-01Not public
Exhibit No. B.162024-11-01Not public
Exhibit No. B.182024-11-01Not public
Exhibit No. B.052024-11-01Not public
Exhibit No. B.16.22024-11-01Not public
Exhibit No. G.072024-11-01Not public
Exhibit No. B.07.32024-11-01Not public
Exhibit No. B.04.72024-11-01Not public
Exhibit No. B.152024-11-01Not public
Exhibit No. B.22.32024-11-01Not public
Exhibit No. D.04 (UNREDACTED)2024-11-01Not public
Exhibit No. B.29 (2)2024-11-01Not public
Exhibit No. B.232024-11-01Not public
Exhibit No. B.192024-11-01Not public
Reply and Defence2024-11-01Not public
Exhibit No. B.04.12024-11-01Not public
Exhibit No. B.05.12024-11-01Not public
Exhibit No. F.022024-11-01Not public
Exhibit No. B.17.12024-11-01Not public
Exhibit No. B.07.52024-11-01Not public
Exhibit No. D.03.32024-11-01Not public
Exhibit No. B.282024-11-01Not public
Exhibit No. B.04.92024-11-01Not public
Exhibit No. B.272024-11-01Not public
Exhibit No. B.22.12024-11-01Not public
Exhibit No. B.25 (3)2024-11-01Not public
Exhibit No. B.102024-11-01Not public
Exhibit No. G.032024-11-01Not public
Exhibit No. D.04 (UNREDACTED)2024-11-01Not public
Exhibit No. B.112024-11-01Not public
Exhibit No. B.07.42024-11-01Not public
Exhibit No. B.142024-11-01Not public
Exhibit No. B.092024-11-01Not public
Exhibit No. B.04.22024-11-01Not public
Exhibit No. B.07.62024-11-01Not public
Exhibit No. G.052024-11-01Not public
Exhibit No. B.04.82024-11-01Not public
Exhibit No. B.032024-11-01Not public
Exhibit No. B.212024-11-01Not public
Exhibit No. B.25 (5)2024-11-01Not public
Exhibit No. B.242024-11-01Not public
Exhibit No. G.012024-11-01Not public
Exhibit No. B.23.12024-11-01Not public
Exhibit No. B.062024-11-01Not public
Exhibit No. B.07.12024-11-01Not public
Exhibit No. B.222024-11-01Not public
Exhibit No. B.25 (4)2024-11-01Not public
Exhibit No. B.29 (1)2024-11-01Not public
Exhibit No. B.04.52024-11-01Not public
Exhibit No. B.202024-11-01Not public
Exhibit No. B.172024-11-01Not public
Exhibit No. G.062024-11-01Not public
Exhibit No. B.17.22024-11-01Not public
Exhibit No. B.04.42024-11-01Not public
Exhibit No. B.25 (1)2024-11-01Not public
Exhibit No. D.03.22024-11-01Not public
Exhibit No. B.082024-11-01Not public
Exhibit No. B.16.12024-11-01Not public
Exhibit No. B.122024-11-01Not public
Exhibit No. B.25 (6)2024-11-01Not public
Exhibit No. B.09.12024-11-01Not public
Exhibit No. B.25 (2)2024-11-01Not public
Exhibit No. B.22.22024-11-01Not public
Exhibit No. B.04.32024-11-01Not public
Exhibit No. G.022024-11-01Not public
Exhibit No. B.07.22024-11-01Not public
Exhibit No. B.262024-11-01Not public
Receipt2024-10-14Not public
2024 10 11- Accord case management request (55895-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord comments on Preliminary order issued on 1 Oct 2024 (ord_54191-2024)2024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
Exhibit PM 6 - Paris Court Judgment issued on 6 September 2024 Accord v Sanofi RG n 21-064162024-10-11Not public
2024 10 11 - Accord Rejoinder to the Claimants comments on the Preliminary Objections (36781-2024)2024-10-11Not public
Exhibit PM 6 - Paris Court Judgment issued on 6 September 2024 Accord v Sanofi RG n 21-064162024-10-11Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Written comments2024-10-10Not public
Exhibit No. F.012024-10-10Not public
Exhibit No. 0.42024-10-10Not public
Exhibit No. A.022024-10-10Not public
Exhibit No. B.01.1b2024-10-10Not public
Written comments2024-10-10Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
R 37.2 - comments2024-10-01Not public
R 19 - comments2024-10-01Not public
R 334 h, 361, 363 - comments2024-10-01Not public
Hearing-Dates2024-09-16Not public
scheduling - final2024-09-16Public
Panel-Appointment2024-09-16Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
2024 09 12 Accord Reponse to the preliminary order (signed)2024-09-12Not public
scheduling - comments2024-09-10Not public
Hearing-Dates2024-09-10Not public
Formal-checks_Notification-of-positive-outcome2024-09-04Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Acknowledgement-of-lodging2024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Acknowledgement-of-lodging2024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Acknowledgement-of-lodging2024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Acknowledgement-of-lodging2024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Acknowledgement-of-lodging2024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Acknowledgement-of-lodging2024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Acknowledgement-of-lodging2024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Acknowledgement-of-lodging2024-08-30Not public
Exhibit PM 5.33 Extracts from Sanofi Annual Report 20082024-08-30Not public
Exhibit PM 2.1 Summary of product characteristics of Jevtana2024-08-30Not public
Exhibit PM 5.2 Annexes to the declaration by Dr Samuel Denmaede (part 3)2024-08-30Not public
Exhibit PM 5.25 De Bono et al. Prednisone plus cabazitaxel or mitoxantrone (...) The Lancet 20102024-08-30Not public
ACT_16112-2024 and 4499-2024_Accord_Statement of Defence and Counterclaim for Revocation_30 August 20242024-08-30Not public
Exhibit PM 5.7 Tannock et al. Docetaxel plus prednisone or mitoxantrone plus prednisone (...) 2004 Oct.2024-08-30Not public
Exhibit PM 5.8 Tannock et al. Chemotherapy with mitoxantrone plus prednisone (...)1996 Jun.2024-08-30Not public
Exhibit PM 2.7 Revue Prescrire Cabazitaxel Jevtana Trop toxique pour une efficacite trop incertaine October 20112024-08-30Not public
Exhibit PM 2.4 Le Monde Sanofi Londres refuse de rembourser le Jevtana of 13 January 20122024-08-30Not public
Exhibit PM 5.2 Annexes to the declaration by Dr. Samuel Denmaede (part 1)2024-08-30Not public
Exhibit PM 5.1 Declaration by Dr. Samuel Denmeade2024-08-30Not public
Exhibit PM 2.4 Le Monde Sanofi Londres refuse de rembourser le Jevtana of 13 January 20122024-08-30Not public
Exhibit PM 3.1 Summary of product characteristics of Cabazitaxel Accord2024-08-30Not public
Exhibit PM 5.16 Oudard et al. Multicenter randomized phase II study (...) May 20052024-08-30Not public
Exhibit PM 4.8 Notice of opposition Accord of 10 March 20212024-08-30Not public
Exhibit PM 5.2 Annexes to the declaration by Dr. Samuel Denmaede (part 2)2024-08-30Not public
Exhibit PM 2.5 Refusal notice issued by the INESSS in February 20152024-08-30Not public
Exhibit PM 1.1 French company registry extract for Sanofi Mature IP2024-08-30Not public
Exhibit PM 2.6 Opinion of the Transparency Committee of the French National Health Authority 17 October 20122024-08-30Not public
Exhibit PM 5.9 ICH Topic E8 Note for guidance on general considerations for clinical trials March 19982024-08-30Not public
Exhibit PM 5.23 Wayback machine extracts from ClinicalTrial.gov. 2008 and 20092024-08-30Not public
Exhibit PM 5.17 Berthold et al. Survival and PSA response of patients in the TAX 327 study2024-08-30Not public
Exhibit PM 4.12 Grounds of appeal Accord of 24 May 20242024-08-30Not public
Exhibit PM 1.3 Communication from the Paris Court of First Instance dated 5 July 20242024-08-30Not public
Exhibit PM 5.22 Sanofi press release dated 21 December 20092024-08-30Not public
Exhibit PM 2.7 Revue Prescrire Cabazitaxel Jevtana Trop toxique pour une efficacite trop incertaine October 20112024-08-30Not public
Exhibit PM 4.1 EP E 493 466 B12024-08-30Not public
Exhibit PM 5.20 Beardsley et al. Systemic therapy after first-line docetaxel (...) 20082024-08-30Not public
Exhibit PM 5.24 Screenshot from ClinicalTrial.gov XRP6258 Plus Prednisone Compared to (...) 3 May 20212024-08-30Not public
Exhibit PM 5.18 Mita et al. Phase I and pharmacokinetic study of XRP6258 (...) 20092024-08-30Not public
Exhibit PM 2.8 Sales of Jevtana in European countries in 2020 (based on IQVIA data)2024-08-30Not public
Exhibit PM 5.19 Pivot et al. A multicenter phase II study of XRP6258 (...) 20082024-08-30Not public
Exhibit PM 5.21 TROPIC trial protocol in a document entitled Cabazitaxel (XRP-6258) for hormone (...) 20092024-08-30Not public
Exhibit PM 5.2 Annexes to the declaration by Dr Samuel Denmaede (part 4)2024-08-30Not public
Exhibit PM 5.32 Madan et al. Overcoming Chemotherapy Resistance in Prostate Cancer (...) June 20112024-08-30Not public
Exhibit PM 4.11 Notice of appeal Accord of 15 January 20242024-08-30Not public
Exhibit PM 1.2 Extract Sanofi annual reports2024-08-30Not public
Exhibit PM 4.4 Priority document No. US 61 293 903 (P2)2024-08-30Not public
Exhibit PM 5.26 Correspondence in The Lancet (2011) re PM 5.25 Froehner and Wirth v. De Bono2024-08-30Not public
Exhibit PM 5.29 Extracts from Dr. Sartor deposition transcript of 8 May 2017 in the US proceedings2024-08-30Not public
Exhibit PM 5.11 Wong and Siah Estimation of clinical trial success rates and related parameters Biostatistics 20192024-08-30Not public
Exhibit PM 5.13 Scher et al. Design and end points of clinical trials for patients (...) 20082024-08-30Not public
Exhibit PM 2.5 Refusal notice issued by the INESSS in February 20152024-08-30Not public
Exhibit PM 6.2 Order 7 June 2022 First Instance Court2024-08-30Not public
Exhibit PM 4.3 Priority document No. US 61 256 160 (P1)2024-08-30Not public
Exhibit PM 5.34 Fitzpatrick et al. Treatment Decisions for Advanced Genitourinary (...) 20092024-08-30Not public
Exhibit PM 5.4 Declaration by Prof. Stefan Muller2024-08-30Not public
Exhibit PM 5.10 CHMP guideline on the evaluation of anticancer medicinal products in man December 20052024-08-30Not public
Exhibit PM 5.28 Declaration by Dr. Sartor before the Patent and trial and appeal board 20 April 20172024-08-30Not public
Exhibit PM 4.10 Opposition Division reasoned decision dated on 25 January 20242024-08-30Not public
Exhibit PM 5.27 Declaration by Dr. Sartor of 23 December 20202024-08-30Not public
Exhibit PM 5.6 Extracts from the Summary of Product Characteristics of Taxotere2024-08-30Not public
Exhibit PM 7.1 Extract Paul England A practioners Guide to the UPC and UP Dec 20222024-08-30Not public
Exhibit PM 5.36 Galletti et al. Paclitaxel and Docetaxel Resistance (...) 20072024-08-30Not public
Exhibit PM 4.6 Summons to oral proceedings by the Board of Appeal and date confirmation2024-08-30Not public
Exhibit PM 4.7 Record of the assignment of EP 466 during its examination before the EPO2024-08-30Not public
Exhibit PM 5.14 Label Novantrone (Mitoxantrone) FDA2024-08-30Not public
Exhibit PM 2.2 Neutropenia MSD Manual2024-08-30Not public
Exhibit PM 4.14 IP.appify Blog of 12 janvier 2024 Caselaw-EPO-reviews of EPO BoA decisions of D.X. Thomas2024-08-30Not public
Exhibit PM 2.3 Opinion of the Transparency Committee of the French National Health Authority of 19 October 20112024-08-30Not public
Exhibit PM 5.3 Declaration by Dr. Kurt Miller2024-08-30Not public
Exhibit PM 5.5 US 2005 065138 A12024-08-30Not public
Exhibit PM 5.31 Kumar Pal et al. Critical appraisal of cabazitaxel (...) Clinical Interventions in Aging 20102024-08-30Not public
Exhibit PM 5.30 Screenshot from OpenPaymentsData.CMS.gov2024-08-30Not public
Exhibit PM 5.35 Extracts Sanofi Annual report 20-F 2008 in the US2024-08-30Not public
Exhibit PM 6.2 Order 7 June 2022 First Instance Court2024-08-30Not public
Exhibit PM 4.9 Further observations Accord of 10 December 20212024-08-30Not public
Exhibit PM 1.1 French company registry extract for Sanofi Mature IP2024-08-30Not public
Exhibit PM 1.3 Communication from the Paris Court of First Instance dated 5 July 20242024-08-30Not public
Exhibit PM 6.1 Excerpts IQVIA Audit Data Presentation July 20242024-08-30Not public
Exhibit PM 5.15 Petrylak et al. Docetaxel and estramustine compared (...) 2004 Oct.2024-08-30Not public
Exhibit PM 5.12 Declaration of Helsinki Ethical Principles of Medical Research involving Human Subjects October 20082024-08-30Not public
Exhibit PM 4.2 WO 2011 051894 A12024-08-30Not public
Exhibit PM 4.13 Decision of the United States Patent Office (USPTO) of 22 October 20192024-08-30Not public
Exhibit PM 4.5 Extracts from the European Patent register for EP 2 493 466 as at 21 August 20242024-08-30Not public
commentPreliminaryObjection2024-07-14Not public
Exhibit No. E.32024-07-14Not public
Exhibit No. E.72024-07-14Not public
Written comments2024-07-14Not public
Exhibit No. E.82024-07-14Not public
Exhibit No. E.22024-07-14Not public
Exhibit No. E.132024-07-14Not public
Exhibit No. E.52024-07-14Not public
Exhibit No. E.122024-07-14Not public
Exhibit No. E.102024-07-14Not public
Exhibit No. E.1.12024-07-14Not public
Exhibit No. 11.12024-07-14Not public
Exhibit No. E.92024-07-14Not public
Exhibit No. E.1.22024-07-14Not public
Exhibit No. E.62024-07-14Not public
Exhibit No. E.32024-07-14Not public
Exhibit No. 11.12024-07-14Not public
Exhibit No. E.92024-07-14Not public
Exhibit No. E.42024-07-14Not public
Exhibit No. E.1.32024-07-14Not public
preliminaryObjection2024-07-02Not public
Receipt2024-07-02Not public
01 07 2024 - Preliminary objections and other requests for the Defendants2024-07-01Not public
Exhibit PM 03 Communication from the Paris Court of First Instance Court dated 19 June 20242024-07-01Not public
Exhibit PM 01 Extract from the European Patent register for EP 2 493 466 (EP Legal Status) as at 27 June 20242024-07-01Not public
Exhibit PM 04 DHL tracking information for service of SoC to Defendant 62024-07-01Not public
Exhibit PM 05 Sales of Jevtana in European countries in 2020 (based on IQVIA data)2024-07-01Not public
Exhibit PM 02 Summons to oral proceedings by the TBA2024-07-01Not public
Exhibit PM 04 DHL tracking information for service of SoC to Defendant 62024-07-01Not public
Exhibit PM 03 Communication from the Paris Court of First Instance Court dated 19 June 20242024-07-01Not public
Exhibit PM 05 Sales of Jevtana in European countries in 2020 (based on IQVIA data)2024-07-01Not public
Exhibit PM 04 DHL tracking information for service of SoC to Defendant 62024-07-01Not public
Exhibit PM 03 Communication from the Paris Court of First Instance Court dated 19 June 20242024-07-01Not public
Exhibit PM 02 Summons to oral proceedings by the TBA2024-07-01Not public
01 07 2024 - Preliminary objections and other requests for the Defendants2024-07-01Not public
Exhibit PM 01 Extract from the European Patent register for EP 2 493 466 (EP Legal Status) as at 27 June 20242024-07-01Not public
Exhibit PM 04 DHL tracking information for service of SoC to Defendant 62024-07-01Not public
Exhibit PM 03 Communication from the Paris Court of First Instance Court dated 19 June 20242024-07-01Not public
Notification Of Service2024-07-01Not public
Proof of service - mail by representative2024-07-01Not public
Notification Of Service2024-06-25Not public
Proof of service2024-06-25Not public
Notification Of Service2024-06-25Not public
Proof of service2024-06-25Not public
Notification Of Service2024-06-20Not public
Proof of service2024-06-20Not public
Notification Of Service2024-06-13Not public
Proof of service2024-06-13Not public
Notification Of Service2024-06-06Not public
Proofl of service2024-06-06Not public
Acknowledgement of access to case2024-06-06Not public
Notification Of Service2024-06-04Not public
Proof of service2024-06-04Not public
Notification Of Service2024-06-04Not public
Proof of service2024-06-04Not public
Acknowledgement of access to case2024-06-03Not public
Acknowledgement of access to case2024-06-03Not public
Panel-Appointment2024-06-03Not public
Acknowledgement of access to case2024-05-31Not public
Acknowledgement of access to case2024-05-30Not public
Acknowledgement of access to case2024-05-30Not public
Acknowledgement of access to case2024-05-30Not public
Acknowledgement of access to case2024-05-30Not public
epoUploadDocumentsWorkflow2024-05-23Not public
Document from EPO2024-05-22Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Panel-Appointment2024-05-16Not public
EPO-Request-for-case-pending2024-05-16Not public
Receipt2024-05-16Not public
Formal-checks_Notification-of-positive-outcome2024-05-16Not public
Exhibit No. D.1.32024-05-14Not public
Exhibit No. C.1.22024-05-14Not public
Exhibit No. B.2.12024-05-14Not public
Exhibit No. 0.12024-05-14Not public
Exhibit No. B.2.22024-05-14Not public
Exhibit No. 0.22024-05-14Not public
Exhibit No. B.1.1.22024-05-14Not public
Exhibit No. B.12024-05-14Not public
Exhibit No. B.2.42024-05-14Not public
Exhibit No. 0.32024-05-14Not public
Exhibit No. D.1.12024-05-14Not public
Exhibit No. D.2.42024-05-14Not public
Exhibit No. 0.12024-05-14Not public
Exhibit No. B.1.22024-05-14Not public
Exhibit No. D.2.12024-05-14Not public
Exhibit No. A.1.12024-05-14Not public
Exhibit No. 0.22024-05-14Not public
Exhibit No. D.32024-05-14Not public
Exhibit No. D.1.42024-05-14Not public
Exhibit No. 0.32024-05-14Not public
Exhibit No. D.3.12024-05-14Not public
Exhibit No. A.12024-05-14Not public
Exhibit No. D.2.32024-05-14Not public
Exhibit No. B.1.12024-05-14Not public
Exhibit No. C.12024-05-14Not public
Exhibit No. D.1.22024-05-14Not public
Statement of claim2024-05-14Not public
Exhibit No. B.1.1.12024-05-14Not public
Exhibit No. B.2.32024-05-14Not public
Exhibit No. D.2.22024-05-14Not public
Amended Statement of claim2024-05-14Not public
Exhibit No. B.2.52024-05-14Not public
Formal-checks_Request-for-correction2024-05-14Not public
Acknowledgement-of-lodging2024-05-13Not public
Exhibit No. B.1.12024-05-13Not public
Exhibit No. 0.32024-05-13Not public
Exhibit No. 0.32024-05-13Not public
Exhibit No. B.2.12024-05-13Not public
Exhibit No. D.2.32024-05-13Not public
Exhibit No. B.12024-05-13Not public
Exhibit No. B.2.52024-05-13Not public
Exhibit No. B.2.32024-05-13Not public
Exhibit No. C.1.22024-05-13Not public
Exhibit No. B.1.22024-05-13Not public
Exhibit No. A.12024-05-13Not public
Exhibit No. D.3.12024-05-13Not public
Exhibit No. B.2.22024-05-13Not public
Exhibit No. B.2.42024-05-13Not public
Exhibit No. D.2.22024-05-13Not public
Exhibit No. 0.22024-05-13Not public
Exhibit No. D.1.32024-05-13Not public
Exhibit No. B.1.1.12024-05-13Not public
Exhibit No. B.1.1.22024-05-13Not public
Statement of claim2024-05-13Not public
Exhibit No. D.32024-05-13Not public
Exhibit No. D.2.42024-05-13Not public
Exhibit No. D.1.22024-05-13Not public
Exhibit No. 0.22024-05-13Not public
Exhibit No. D.1.12024-05-13Not public
Exhibit No. A.1.12024-05-13Not public
Exhibit No. 0.12024-05-13Not public
Exhibit No. C.12024-05-13Not public
Exhibit No. D.2.12024-05-13Not public
Exhibit No. 0.12024-05-13Not public
Exhibit No. D.1.42024-05-13Not public